Empresa Dyadic International, Inc. Other OTC
Acciones
US26745T1016
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Industrial Enzymes and Other Proteins
100,0
%
| 3 | 100,0 % | 3 | 100,0 % | -1,07 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States and Netherlands
100,0
%
| 3 | 100,0 % | 3 | 100,0 % | -1,07 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mark Emalfarb
FOU | Founder | 69 | 01/01/79 |
Ping Rawson
DFI | Director of Finance/CFO | 48 | 01/06/16 |
Joseph Hazelton
COO | Chief Operating Officer | 48 | 09/11/21 |
Ronen Tchelet
CTO | Chief Tech/Sci/R&D Officer | 66 | 06/05/14 |
Doug Pace
PRN | Corporate Officer/Principal | - | 09/10/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Mark Emalfarb
FOU | Founder | 69 | 01/01/79 |
Jack Kaye
BRD | Director/Board Member | 80 | 01/05/15 |
Michael Tarnok
BRD | Director/Board Member | 69 | 12/06/14 |
Patrick Lucy
CHM | Chairman | 56 | 08/01/21 |
Seth Herbst
BRD | Director/Board Member | 66 | 20/06/08 |
Barry Buckland
BRD | Director/Board Member | 76 | 03/01/18 |
Arindam Bose
BRD | Director/Board Member | 71 | 15/08/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 41 490 316 | 20 348 574 ( 49,04 %) | 12 253 502 ( 29,53 %) | 49,04 % |
Información de la empresa
Dyadic International, Inc.
1044 North US Highway One Suite 201
33477-5094, Jupiter
+
http://www.dyadic.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,03 % | 49,18 mil M | |
-0,10 % | 42,11 mil M | |
+43,45 % | 40,37 mil M | |
-5,26 % | 28,85 mil M | |
+11,48 % | 26,09 mil M | |
-22,74 % | 18,71 mil M | |
+9,06 % | 13,26 mil M | |
+30,01 % | 12,32 mil M | |
-1,51 % | 11,99 mil M |